Category: Joint ventures/collaborations
-
Software Companies Integrate Cancer Analytics, Patient Mgmt
26 May 2015. Two companies with software addressing different perspectives of cancer care agreed to offer an integrated version of their products. Flatiron Health in New York, a developer of cancer analytics, and Varian Medical Systems in Palo Alto, California, a provider of decision support software for cancer care, announced the deal today, but released…
-
Mobile App Data Provided for Chronic Pain Study
21 May 2015. Data collected by a mobile app designed to help individuals manage their pain are being provided to a research lab at York University to reveal patterns in painful experiences by the app’s users. York’s Human Pain Mechanisms Lab in Toronto, Ontario, Canada will analyze data provided by the app Manage My Pain,…
-
Sanford-Burnham, Lilly Partnering on Immune Therapies
14 May 2015. Sanford-Burnham Research Institute and Eli Lilly and Company are collaborating on discovering new therapies for immune system disorders using biotechnology tools. Financial and intellectual property aspects of their agreement were not disclosed. The partnership aims to combine Sanford-Burnham’s experience in cell communication pathways with Eli Lilly’s work in biotechnology applied to immunological…
-
Mayo Clinic, Baylor to Study Genomes for Drug Safety
13 May 2015. Mayo Clinic and Baylor College of Medicine are beginning a study of 10,000 human genomes to reveal drug safety problems and highlight where drugs may not work for some people. Financial aspects of the collaboration, involving Mayo Clinic’s Biobank and Baylor’s Human Genome Sequencing Center, were not disclosed. The research aims to…
-
Biotech, Research Institute Partner on Gene Therapies
13 May 2015. A collaboration between a U.S. biotechnology company and French research institute is enhancing current techniques to allow patients with rare diseases to receive multiple doses of gene therapies. Selecta Biosciences in Watertown, Masachusetts and Généthon in Evry, France plan to co-develop and co-own the results of their partnership, but financial details of…
-
RNA Therapies Developer Spins-Off Rare Disease Venture
12 May 2015. Moderna Therapeutics, a developer of RNA-based treatments, is starting a new company to design therapies with its technology to address rare diseases. Financial details of the spin-off company Elpidera LLC, the third such venture launched by Moderna, were not disclosed. Moderna, a biotechnology enterprise in Cambridge, Massachusetts, develops medications that use genetic…
-
GSK, UNC Chapel Hill Partner on HIV/AIDS Cure
11 May 2015. Pharmaceutical maker GlaxoSmithKline and University of North Carolina in Chapel Hill are establishing a joint research center and spin-off company to develop new treatments for HIV and AIDS. GSK says it plans to invest $20 million over 5 years for a new HIV Cure Center on the Chapel Hill campus to conduct…
-
23andMe, Lupus Institute Partner on Genetics Study
5 May 2015. The personal genetics company 23 andMe and Lupus Research Institute are collaborating on a study of genetic associations with systemic lupus erythematosus, the disease more commonly known as lupus. Financial and intellectual property details of the collaboration between 23andMe, Lupus Research Institute, and Pfizer Inc. serving as an adviser to the project,…
-
Janssen Licensing DNA Technology for Hep B Vaccine
13 April 2015. Janssen Pharmaceuticals, a division of Johnson & Johnson, is licensing an electronic DNA drug delivery technology from Ichor Medical Systems for vaccines to treat hepatitis B. Ichor, based in San Diego, expects to gain as much as $85 million in the deal. Hepatitis B is a liver infection caused by a virus…
-
North Texas Campuses Researching Assistive Technologies
10 April 2015. Two University of Texas campuses, in Dallas and nearby Arlington, formed a research center to study software solutions for assistive technologies that benefit disabled and able-bodied people alike. The iPerform Center for Assistive Technologies to Enhance Human Performance, funded for five years by National Science Foundation, is also enlisting industry partners that…